Gotowa bibliografia na temat „Cancer”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Cancer”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Cancer"
Basch, Corey H., Charles E. Basch, Grace Clarke Hillyer i Rachel Reeves. "YouTube Videos Related to Skin Cancer: A Missed Opportunity for Cancer Prevention and Control". JMIR Cancer 1, nr 1 (2.03.2015): e1. http://dx.doi.org/10.2196/cancer.4204.
Pełny tekst źródłaJabour, Abdulrahman M., Brian E. Dixon, Josette F. Jones i David A. Haggstrom. "Toward Timely Data for Cancer Research: Assessment and Reengineering of the Cancer Reporting Process". JMIR Cancer 4, nr 1 (1.03.2018): e4. http://dx.doi.org/10.2196/cancer.7515.
Pełny tekst źródłaCorbett, Teresa, Jane C. Walsh, AnnMarie Groarke, Rona Moss-Morris, Eimear Morrissey i Brian E. McGuire. "Cancer-Related Fatigue in Post-Treatment Cancer Survivors: Theory-Based Development of a Web-Based Intervention". JMIR Cancer 3, nr 2 (4.07.2017): e8. http://dx.doi.org/10.2196/cancer.6987.
Pełny tekst źródłaWilliams, Kate, Abigail Fisher, Rebecca J. Beeken i Jane Wardle. "Availability of Information About Lifestyle for Cancer Survivors in England: A Review of Statutory and Charitable Sector Organizations and Cancer Centers". JMIR Cancer 1, nr 1 (9.03.2015): e2. http://dx.doi.org/10.2196/cancer.3521.
Pełny tekst źródłaBaseman, Janet, Debra Revere i Laura-Mae Baldwin. "A Mobile Breast Cancer Survivorship Care App: Pilot Study". JMIR Cancer 3, nr 2 (26.09.2017): e14. http://dx.doi.org/10.2196/cancer.8192.
Pełny tekst źródłavan Eenbergen, Mies C., Lonneke V. van de Poll-Franse, Emiel Krahmer, Suzan Verberne i Floortje Mols. "Analysis of Content Shared in Online Cancer Communities: Systematic Review". JMIR Cancer 4, nr 1 (3.04.2018): e6. http://dx.doi.org/10.2196/cancer.7926.
Pełny tekst źródłaSato, Akira, Eiji Aramaki, Yumiko Shimamoto, Shiro Tanaka i Koji Kawakami. "Blog Posting After Lung Cancer Notification: Content Analysis of Blogs Written by Patients or Their Families". JMIR Cancer 1, nr 1 (18.05.2015): e5. http://dx.doi.org/10.2196/cancer.3883.
Pełny tekst źródłaCarter, Wendy, Karen Fergus, Saunia Ahmad, Deborah McLeod i Joanne Stephen. "Defining the Role of the Online Therapeutic Facilitator: Principles and Guidelines Developed for Couplelinks, an Online Support Program for Couples Affected by Breast Cancer". JMIR Cancer 1, nr 1 (14.04.2015): e4. http://dx.doi.org/10.2196/cancer.3887.
Pełny tekst źródłaKilsdonk, Ellen, Eline van Dulmen-den Broeder, Helena J. van der Pal, Nynke Hollema, Leontien C. Kremer, Marry M. van den Heuvel-Eibrink, Flora E. van Leeuwen, Monique W. Jaspers i Marleen H. van den Berg. "Effect of Web-Based Versus Paper-Based Questionnaires and Follow-Up Strategies on Participation Rates of Dutch Childhood Cancer Survivors: A Randomized Controlled Trial". JMIR Cancer 1, nr 2 (24.11.2015): e11. http://dx.doi.org/10.2196/cancer.3905.
Pełny tekst źródłaKim, Matthew. "Evaluation of a Web-Based App Demonstrating an Exclusionary Algorithmic Approach to TNM Cancer Staging". JMIR Cancer 1, nr 1 (2.04.2015): e3. http://dx.doi.org/10.2196/cancer.4019.
Pełny tekst źródłaRozprawy doktorskie na temat "Cancer"
CATTIER, JEAN-MICHEL. "Contribution a l'etude de l'anurie dans les cancers pelviens : cancer de prostate, cancer colo-rectal, cancer du col de l'uterus". Limoges, 1988. http://www.theses.fr/1988LIMO0208.
Pełny tekst źródłaFruka, Tayra. "An evaluation of cancer biomarkers in normal ovarian epithelial cells and ovarian cancer cell lines". University of the Western Cape, 2019. http://hdl.handle.net/11394/6920.
Pełny tekst źródłaIntroduction: Globally, there are over 190,000 new reported cases of ovarian cancers per annum. This comprises 3% to 4% of all cancers in women. Ovarian cancer is one of the leading causes of deaths in women. Ovarian cancer is the second most diagnosed gynaecological malignancy and over all the fifth cause leading to death among all types of cancer in the UK in 2004. More than 70% of epithelial ovarian cancers are diagnosed at an advanced stage. Consequently, the prognosis is poor and the mortality rate high. Thus, the survival rate is affected by how far the disease has progressed or spread. A dire need exists to identify ovarian cancer biomarkers, which could be used as good indicators of expression in ovarian cancer cells in vitro Aim: The aim of this study was to analyse selected cancer biomarkers, which are currently under intense investigation for their suitability to diagnose epithelial ovarian cancer at an early stage. These biomarkers were analysed in terms of their in vitro expression in normal epithelial cells and ovarian cancer cell lines, which allows for their genomic and proteomic classification. The expression analysis of each biomarker is related to the malignancy of a tumour and, therefore, advocates its use for potential future improvement of sensitive tumour markers. Methods: The primary human ovarian surface epithelial cell line (HOSEpiC), SKOV-3 cells and the OAW42 human epithelial ovarian tumour cell lines were used to evaluate the selected cancer biomarkers. Cells were cultured using appropriate media and supplements, and real-time quantitative polymerase chain reaction (RT-PCR) utilized to validate expression levels of the following genes: HDAC1, HDAC2, HDCA3, HDAC5, HDAC6, HDAC7, HDAC8, LPAR1, LPAR2, MUC16 and FOSL1, against normal housekeeping genes GAPDH and HPRT. In addition, immunocytochemistry was also used in the validation process of the aforementioned genes. Significance: ovarian cancer cells express gene signatures, which pose significant challenges for cancer drug development, therapeutics, prevention and management. The present study is an effort to explore ovarian cancer biomarkers to provide a better diagnostic method that may offer translational therapeutic possibilities to increase five- year survival rate. Results: HDAC5, HDAC6, LPAR1, LPAR2 and MUC16 expressed distinctively in ovarian cancers matched to other tissues or cancer types have already been identified by RT-QPCR and confirmed by immunocytochemistry and efforts to generate monoclonal antibodies to the other six genes (HDAC1, HDAC2, HDAC3, HDAC7, HDAC8 and FOSL1) encoded proteins are underway. Conclusions: here we provide strong evidence suggesting that HDAC5, HDAC6, LPAR1, LPAR2, except MUC16 are up regulated in ovarian cancer. These data were confirmed by examining Human Protein Atlas (HPA) databases, in addition to protein expression of HDAC5, HDAC6, LPAR1, LPAR2 and MUC16 in cells cytoplasm. For future prospective, using other techniques that assess the variant expression that could explain the release of these gene candidates into the circulation with serum tumour markers, and protein expression will be strengthened.
Engler, Jennifer [Verfasser]. "Cancer Care and Cancer Patients’ Experiences with Cancer / Jennifer Engler". Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2019. http://d-nb.info/1180994191/34.
Pełny tekst źródłaStocks, Tanja. "Metabolic factors and cancer risk : prospective studies on prostate cancer, colorectal cancer, and cancer overall". Doctoral thesis, Umeå universitet, Urologi och andrologi, 2009. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-22567.
Pełny tekst źródłaEberst, Guillaume Nicolas. "Seconds cancers après traitement curatif d'un cancer broncho-pulmonaire". Electronic Thesis or Diss., Bourgogne Franche-Comté, 2023. http://www.theses.fr/2023UBFCE029.
Pełny tekst źródłaThe first objective of the 2014-2019 cancer plan was to cure more patients by promoting earlier diagnosis. This objective gives hope for more diagnosis at early stages accessible to surgical resection. Currently, excisional surgery for non-small cell bronchopulmonary cancer (NSCLC) is the treatment offering the most hope for a cure. This thesis work is particularly interested in the future of operated patients.Despite a curative intention, patients operated on for NSCLC are at risk of recurrence of the operated cancer but also have a higher risk of second cancer, and in particular second primary lung cancer (SPLC), higher than that of the general population. , of the order of 20% cumulative incidence at 10 years.When a lung lesion with the same histological diagnosis as the operated cancer occurs, the differential diagnosis between recurrence of the operated cancer or SPLC is difficult. Several definitions exist. Based on the hypothesis that recurrences indicate an aggressiveness of the cancerous disease, and therefore most often have a worse prognosis than second cancers, we first conducted a Cochrane systematic review of the set of definitions used in the literature in order to identify the one which offers the best prognostic distinction, on which to base the differential diagnosis between recurrence of operated cancer and SCBP.A few years ago, immunotherapy established itself in the therapeutic arsenal for bronchopulmonary cancer. First used in the metastatic situation, immunotherapy is now tested in the perioperative situation in numerous trials. However, due to the diversity of combinations and therapeutic strategies, not all of which have been compared with each other, uncertainty remains regarding the best perioperative therapy for patients undergoing surgery for early-stage NSCLC. We initiated a systematic review of interventional trials with network meta-analysis according to the Cochrane method on the effectiveness of these perioperative treatments in patients with non-small cell lung cancer.The IFCT-0302 study is the only large randomized surveillance study of NSCLC patients. It included 1775 patients. Its objective was to compare the overall survival of two monitoring strategies: by clinic and chest x-rays in the control group, and by clinic, chest x-rays and thoraco-abdominal scans in the experimental group. Patient-described quality of life (HRQoL) is a measure of three domains of perceived health: physical, social, and emotional. QoL is impacted by a medical condition or its treatment. Evidence suggests that lung cancer surgery has a significant impact on QoL. The objective of our work was to evaluate the influence of the type of surveillance on HRQoL in the population of the IFCT-0302 study.When an abnormal lung image is detected, its histological diagnosis is frequently obtained by transthoracic puncture guided by the scanner. The main complication of the procedure is pneumothorax. Hospital constraints do not allow all patients to be hospitalized after a transthoracic puncture. In this third axis, we worked on the validation of a predictive score for the occurrence of delayed pneumothorax after a CT-guided transparietal lung biopsy, in order to select patients who must be monitored in conventional hospitalization. This work was carried out on a cohort of patients from Besançon University Hospital, one part of the cohort having made it possible to develop the score, the other to validate it. Finally, external validation work on a cohort of patients from the Bichat – Claude Bernard Hospital was carried out
Pieters, Huibrie. "From 'Cancer Patient' to 'Cancer Survivor' oldest breast cancer survivors in transition /". Diss., Restricted to subscribing institutions, 2009. http://proquest.umi.com/pqdweb?did=2023818721&sid=1&Fmt=2&clientId=1564&RQT=309&VName=PQD.
Pełny tekst źródłaJégu, Jérémie. "Cancer ultérieur chez les survivants d'un premier cancer : incidence et impact sur la survie". Thesis, Strasbourg, 2014. http://www.theses.fr/2014STRAJ006/document.
Pełny tekst źródłaThe objectives of this PhD thesis were: to study the trends of the risk of second primary cancer (SPC) among patients with a head and neck (HNSCC) cancer in Bas-Rhin, to provide first nationwide estimates of the risk of SPC in France and to assess the survival of patients with a HNSCC depending on their history of cancer. This work showed that : 1) The excess risk of SPC of head and neck and esophagus sites decreased by 53% over three decades among patients with a HNSCC, and that the excess risk of SPC of the lung did not change significantly. 2) The risk of SPC among cancer survivors in France was increased by 36% compared to the general population. 3) History of cancer was strongly associated with survival among HNSCC patients. Several epidemiological and clinical research perspectives can be established based on this work. These results also present an interest in a public health perspective in the framework of the third cancer plan
陳潔盈 i Kit-ying Loucia Chan. "Expression analysis of Candidate cancer genes in non-small cell lung cancer". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2007. http://hub.hku.hk/bib/B45011163.
Pełny tekst źródłaSoerjomataram, Isabelle. "Multiple primary cancers in patients with breast ans skin cancer". [S.l.] : Rotterdam : [The Author] ; Erasmus University [Host], 2007. http://hdl.handle.net/1765/10779.
Pełny tekst źródłaAlmutairi, Mikhlid Hammad. "Identification of novel human cancer-testis-antigen genes in cancers". Thesis, Bangor University, 2014. https://research.bangor.ac.uk/portal/en/theses/identification-of-novel-human-cancertestisantigen-genes-in-cancers(015fda5b-5bd3-42c1-a610-811f0acde19a).html.
Pełny tekst źródłaKsiążki na temat "Cancer"
Otto, Florian, i Manfred P. Lutz, red. Early Gastrointestinal Cancers II: Rectal Cancer. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-08060-4.
Pełny tekst źródłaTimmermann, Carsten, i Elizabeth Toon, red. Cancer Patients, Cancer Pathways. London: Palgrave Macmillan UK, 2012. http://dx.doi.org/10.1057/9781137272089.
Pełny tekst źródłaWyatt, Debbie, i Nicholas Hulbert-Williams. Cancer and Cancer Care. 1 Oliver’s Yard, 55 City Road London EC1Y 1SP: SAGE Publications Ltd, 2015. http://dx.doi.org/10.4135/9781473920620.
Pełny tekst źródłaNational Cancer Institute (U.S.), red. President's Cancer Panel, National Cancer Program: Cancer and poverty. Silver Spring, Md: Eberlin Reporting Center, 1991.
Znajdź pełny tekst źródłaBozzone, Donna M. Biology of cancer: Cancer genetics. New York NY: Chelsea House, 2007.
Znajdź pełny tekst źródłaWhitehouse, J. M. A. Cancer. Wyd. 2. Oxford: Oxford University Press, 1996.
Znajdź pełny tekst źródłaBose, S. M. Cancer. New Delhi: National Book Trust, India, 2002.
Znajdź pełny tekst źródłaRodgers, Joann Ellison. Cancer. New York: Chelsea House, 1990.
Znajdź pełny tekst źródłaHerda, D. J. Cancer. New York: F. Watts, 1989.
Znajdź pełny tekst źródłaBradbury, Robert H., red. Cancer. Berlin, Heidelberg: Springer Berlin Heidelberg, 2007. http://dx.doi.org/10.1007/978-3-540-33120-9.
Pełny tekst źródłaCzęści książek na temat "Cancer"
Zarisfi, Mohammadreza, Tu Nguyen, Jessie R. Nedrow i Anne Le. "The Heterogeneity Metabolism of Renal Cell Carcinomas". W The Heterogeneity of Cancer Metabolism, 117–26. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-65768-0_8.
Pełny tekst źródłaMorris, Katrina Marie, i Katherine Belov. "Cancer Immunology of Transmissible Cancers". W Cancer Immunology, 419–28. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-662-44006-3_22.
Pełny tekst źródła"Colorectal Cancer: An Overview". W Gastrointestinal Cancers. Exon Publications, 2022. http://dx.doi.org/10.36255/exon-publications-gastrointestinal-cancers-colorectal-cancer.
Pełny tekst źródła"Organ Sparing Surgery in Testicular Cancer". W Urologic Cancers. Exon Publications, 2022. http://dx.doi.org/10.36255/exon-publications-urologic-cancers-testicular-cancer.
Pełny tekst źródła"Prostate Cancer Diagnosis: Biopsy Approaches". W Urologic Cancers. Exon Publications, 2022. http://dx.doi.org/10.36255/exon-publications-urologic-cancers-prostate-cancer-biopsy.
Pełny tekst źródła"The Etiology of Bladder Cancer". W Urologic Cancers. Exon Publications, 2022. http://dx.doi.org/10.36255/exon-publications-urologic-cancers-etiology-bladder-cancer.
Pełny tekst źródła"The Epidemiology of Testicular Cancer". W Urologic Cancers. Exon Publications, 2022. http://dx.doi.org/10.36255/exon-publications-urologic-cancers-epidemiology-testicular-cancer.
Pełny tekst źródła"The Epidemiology of Penile Cancer". W Urologic Cancers. Exon Publications, 2022. http://dx.doi.org/10.36255/exon-publications-urologic-cancers-epidemiology-penile-cancer.
Pełny tekst źródła"The Epidemiology of Stomach Cancer". W Gastrointestinal Cancers. Exon Publications, 2022. http://dx.doi.org/10.36255/exon-publications-gastrointestinal-cancers-stomach-cancer-epidemiology.
Pełny tekst źródła"Improving Prostate Cancer Care through Quality Assurance Programs". W Urologic Cancers. Exon Publications, 2022. http://dx.doi.org/10.36255/exon-publications-urologic-cancers-prostate-cancer-care.
Pełny tekst źródłaStreszczenia konferencji na temat "Cancer"
Rodrigues, Milena de Freitas, Ariane Silva da Rocha, David Siqueira Gonçalves, Maria Paula Curado i Maria Nirvana da Cruz Formiga. "Hereditary cancer syndromes in patients with second primary breast cancer". W Brazilian Breast Cancer Symposium 2023. Mastology, 2023. http://dx.doi.org/10.29289/259453942023v33s1067.
Pełny tekst źródłaLacerda, Elisângela de Paula Silveira, Rebeca Mota Goveia, Paula Francinete Faustino Silva, Thais Bonfim Teixeira i Ruffo de Freitas-Junior. "HEREDITARY BREAST AND OVARIAN CANCER PATIENTS HAVE A FAMILY HISTORY OF CANCER OUTSIDE THE SPECTRUM OF THE SYNDROME, MIMICKING LYNCH AND LI–FRAUMENI SYNDROMES". W Abstracts from the Brazilian Breast Cancer Symposium - BBCS 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s2030.
Pełny tekst źródłaHider, Nabilah Hanani, Anis Salwa Binti Mohd Khairuddin i Effariza Binti Hanafi. "VGG Classification Model for Lung Cancer Diagnosis". W International Technical Postgraduate Conference 2022. AIJR Publisher, 2022. http://dx.doi.org/10.21467/proceedings.141.9.
Pełny tekst źródłaMelo, Maria Eduarda Bernardino Martins, Gabriela Prado Lopes, Darley Lima Ferreira Filho, Irnanda Layanna Gomes Oliveira i Maria Eduarda Vasconcelos Florêncio Cavalcanti. "MALE BILATERAL BREAST CANCER: CASE REPORT". W Scientifc papers of XXIII Brazilian Breast Congress - 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s1077.
Pełny tekst źródłaMoreno, Andre, Kimberly Masiero Cola, Larissa Heberle i Marcelo Moreno. "RELATIONSHIP BETWEEN IMMUNOHISTOCHEMICAL CHARACTERIZATION AND FORM OF DIAGNOSIS OF BREAST CANCER". W Scientifc papers of XXIII Brazilian Breast Congress - 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s1008.
Pełny tekst źródłaEl-Helou, Etienne, Catalin-Florin Pop, Ammar Shall, Manar Zaiter, Jessica Naccour, Huu Hoang, Thi Hoa Nguyen i Xuan Dung Ho. "PRIMARY INVASIVE DUCTAL CARCINOMA OF AXILLARY ACCESSORY BREAST". W Brazilian Breast Cancer Symposium 2022. Mastology, 2022. http://dx.doi.org/10.29289/259453942022v32s2094.
Pełny tekst źródłaLiu, Ziyu, Wei Shao, Jie Zhang, Min Zhang i Kun Huang. "Transfer Learning via Optimal Transportation for Integrative Cancer Patient Stratification". W Thirtieth International Joint Conference on Artificial Intelligence {IJCAI-21}. California: International Joint Conferences on Artificial Intelligence Organization, 2021. http://dx.doi.org/10.24963/ijcai.2021/380.
Pełny tekst źródła"Case series: Breast and ovarian cancer syndrome". W 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685364.
Pełny tekst źródła"Case series: Breast and ovarian cancer syndrome". W 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685348.
Pełny tekst źródłaFerreira, Guilherme Ribeiro, Bianca Dias Socci, Héctor Hugo Queiroz Francto, Yasmin Arroyo de Moraes i João Lucas de Moraes. "Breast cancer mortality in Brazil between the years 2000 and 2020: ecological study". W II INTERNATIONAL SEVEN MULTIDISCIPLINARY CONGRESS. Seven Congress, 2023. http://dx.doi.org/10.56238/homeinternationalanais-026.
Pełny tekst źródłaRaporty organizacyjne na temat "Cancer"
Ramsey, Imogen, Kate Kennedy, Deborah Forsythe, Micah Peters, Greg Sharplin, Nadia Corsini i Marion Eckert. Cancer control plans. The Sax Institute, czerwiec 2020. http://dx.doi.org/10.57022/jkea9139.
Pełny tekst źródłaAziz, Md Abdul, Tahmina Akter i Mohammad Safiqul Islam. Effect of miR-196a2 rs11614913 polymorphism on cancer susceptibility: evidence from an updated meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, maj 2022. http://dx.doi.org/10.37766/inplasy2022.5.0027.
Pełny tekst źródłaFreire, Mariana, Diana Martins, Maria Filomena Botelho i Fernando Mendes. Biomarkers of resistance mechanisms in innovative lung cancer treatments - A systematic Review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, wrzesień 2022. http://dx.doi.org/10.37766/inplasy2022.9.0011.
Pełny tekst źródłaParsons, Helen M. Nutrition as Prevention for Improved Cancer Health Outcomes. Agency for Healthcare Research and Quality (AHRQ), maj 2023. http://dx.doi.org/10.23970/ahrqepccer260.
Pełny tekst źródłaStanton, Elliot, i Natasha Mutebi. Food, diet, nutrition and cancer. Parliamentary Office of Science and Technology, UK Parliament, kwiecień 2024. http://dx.doi.org/10.58248/pn718.
Pełny tekst źródłaMoxham-Hall, Vivienne, Anton du Toit, Sallie Newell, Stuart Brentnall, Deshanie Rawlings i Eileen Goldberg. Proton beam therapy: A rapid review of the evidence since 2020. The Sax Institute, kwiecień 2023. http://dx.doi.org/10.57022/tjvf1783.
Pełny tekst źródłaSquiers, Linda, Mariam Siddiqui, Ishu Kataria, Preet K. Dhillon, Aastha Aggarwal, Carla Bann, Molly Lynch i Laura Nyblade. Perceived, Experienced, and Internalized Cancer Stigma: Perspectives of Cancer Patients and Caregivers in India. RTI Press, kwiecień 2021. http://dx.doi.org/10.3768/rtipress.2021.rr.0044.2104.
Pełny tekst źródłaWang, Ying yuan, Zechang Chen, Luxin Zhang, Shuangyi Chen, Zhuomiao Ye, Tingting Xu i Yingying Zhang c. A systematic review and network meta-analysis: Role of SNPs in predicting breast carcinoma risk. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, luty 2022. http://dx.doi.org/10.37766/inplasy2022.2.0092.
Pełny tekst źródłaKang, Jing, Jun Zhang, Zongsheng Tian, Ye Xu, Jiangbi Li i Mingxina Li. The efficacy and safety of immune-checkpoint inhibitor plus chemotherapy versus chemotherapy for non-small cell lung cancer: an updated systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, maj 2022. http://dx.doi.org/10.37766/inplasy2022.5.0156.
Pełny tekst źródłaWang, Yan, Wenpeng Song, Sicheng Zhou, Jie Tian, Yingxian Dong, Jue Li, Junke Chang i in. Increased risk for subsequent primary lung cancer among female hormone-related cancer patients: a meta-analysis based on over four million cases. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, lipiec 2022. http://dx.doi.org/10.37766/inplasy2022.7.0044.
Pełny tekst źródła